Sarcomas are rare tumours of the connective tissues that account for less than 1% of all malignant tumours. Differentiating benign from possible malignant lesions is challenging and this uncertainty can result in delays in diagnosis and treatment. This article focuses on improving primary care awareness of the key clinical features of sarcoma and discusses which cases should be appropriately referred under the 2-week rule.
Get full access to this article
View all access options for this article.
References
1.
CasaliP. G.BlayJ. V. (2010) Consensus panel of experts. Soft tissue sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology21: 198–203. doi: 10.1093/annonc/mdq209.
GrimerR. J. (2006) Size matters for sarcomas!. Annals of the Royal College of Surgeons England88(6): 519–524. doi: 10.1308/003588406X130651.
4.
Grimer, R., Judson, I., Peake, D., & Seddon, B. (2010). Guidelines for the management of soft tissue sarcomas. Retrieved from www.hindawi.com/journals/srcm/2010/506182/.
5.
HoekstraH. J.ThijssensK.Van GinkelR. J. (2004) The role of surgery as primary treatment and as intervention in the multidisciplinary treatment of soft tissue sarcoma. Annals of Oncology15(4): 181–186. doi: 10.1093/annonc/mdh924.
6.
JainS.KapoorG. (2010) Chemotherapy in Ewing's sarcoma. Indian Journal of Orthopaedics44(4): 369–377. doi: 10.4103/0019-5413.69305.
7.
KindblomL. G.RemottiH. E.AldenborgF.Meis-KindblomJ. M. (1998) Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. American Journal of Pathology152(5): 1259–1269. Retrieved from www.ncbi.nlm.nih.gov/pmc/articles/PMC1858579/pdf/amjpathol00017-0151.pdf.
8.
Malik, A., Wigney, L., Murray, S., & Gerrand, C. H. (2007). The effectiveness of “two-week” referrals for suspected bone and soft tissue sarcoma. Sarcoma. Article ID 23870. doi: 10.1155/2007/23870.
NilssonB.BummingP.Meis-KindblomJ. M.OdenA.DortokA.GustavssonB.…, KindblomL. G. (2005) Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era–a population-based study in western Sweden. Cancer103(4): 821–829. doi: 10.1002/cncr.20862.
12.
PencavelT.StraussD.ThomasG.ThomasJ.HayesA. J. (2010) Does the two-week rule pathway improve the diagnosis of soft tissue sarcoma? A retrospective review of referral patterns and outcomes over five years in a regional centre. Annals of the Royal College of Surgeons England92: 417–421. doi: 10.1308/003588410X12664192075972.
Shmookler, B., Bickels, J., Jelinek, J., Sugarbaker, P., & Malawer, M. (2004). Bone and soft tissue sarcomas: Epidemiology, radiology, pathology and fundamentals of surgical treatment. In Musculoskeletal cancer surgery (pp. 3–35). Washington: Kluwer Academic Publishers.
15.
SinhaS.PeachH. S. (2010) Diagnosis and management of soft tissue sarcoma. British Medical Journal341: c7170–c7170. doi: 10.1136/bmj.c7170.
16.
Taylor, W. S. J., Grimer, R. J., Carter, S. R., Tillman, R. M., Abudu, A., & Jeys, L. (2010). Two-week waits – are they leading to earlier diagnosis of soft-tissue sarcomas? Sarcoma, article ID 312648. doi: 10.1155/2010/312648.
17.
Vander GriendR. A. (1996) Osteosarcoma and its varients. Orthopaedic Clinics of North America27(3): 575–581.
18.
YangJ. C.ChangA. E.BakerA. R.SindelarW. F.DanforthD. N.TopalianS. L.…, RosenbergS. A. (1988) Randomised prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. Journal of Clinical Oncology16: 197–203.
